Related Experiment Videos
[Understanding in treating gliomas: an adequate experimental model for each question]
Sophie Javerzat1, Andréas Bikfalvi, Martin Hagedorn
1Inserm EMI113, avenue des Facultés, 33405 Talence.
Bulletin Du Cancer
|August 27, 2005
Summary
Developing accurate in vivo models for malignant glioma is challenging. This review explores recent strategies for creating relevant glioma models to identify new therapeutic targets and understand drug resistance.
Area of Science:
- Neuro-oncology
- Cancer Biology
- In vivo modeling
Context:
- Malignant gliomas present significant challenges for in vivo modeling.
- Accurate preclinical models are crucial for advancing glioma research.
Purpose:
- To review the latest strategies for developing relevant in vivo models of malignant glioma.
- To highlight the importance of these models for identifying novel therapeutic targets and understanding drug resistance.
Summary:
- This review discusses recent advancements in creating in vivo models for malignant glioma.
- It covers strategies to enhance model relevance for studying tumor biology and treatment response.
Impact:
- Improved glioma models will accelerate the discovery of new tumor-regulating molecules.
- These models will facilitate the testing of inhibitors in therapeutic trials and assess associated drug resistance.